Providing Pregnant Women with their Own Personalized Report – Univfy

IVF success that’s affordable for you

Univfy is dedicated to helping women realize their dream of having a baby. It consists of IVF and fertility analytics experts passionate about providing women with the tools to choose IVF with greater confidence, success and cost-success transparency.

The Univfy platform enables fertility doctors to provide accurate, personalized IVF treatment success prediction to help more women qualify for special pricing plans such as refund programs. The company was founded by Stanford University researchers in 2009.

Personalized Financial Options

The Univfy Platform supports IVF centres in developing special pricing programs that make multiple IVF treatments more affordable. Every woman has a much higher chance of having a baby from IVF if she could afford to have at least 2 or 3 treatments.

The Univfy Platform — using machine learning and AI — can qualify 50-80% of patients for a refund program offer, while traditional refund programs (or shared risk programs) are limited to very few patients.

The Univfy^® PreIVF™ Report

The Report is personalized to you and scientifically validated using the centre’s data. Through technology developed by Stanford University researchers, Univfy uses a rigorous scientific process to develop and validate a customized prediction model for each centre in the Univfy Network.

The Personalized UnivfyPreIVF Report Will Show:

• The probability of having a baby with IVF in the first three cycles
• How the chances compare with others like the women at the IVF centre.
• Individual factors impacting the chances of success
• The Reproductive History
• The Financial Options

The Predictive Univfy^® Platform

Univfy makes predictions of women’s chances of having a baby with each IVF cycle based on the analysis of dozens of key factors in the health profile together, including the age, body mass index, ovarian reserve test results, the reproductive history and clinical diagnosis. Using this personalized approach and leveraging machine learning and data modelling, Univfy is able to predict the IVF success rate with more than 95% accuracy.

Knowing the IVF success probabilities can help the women and the doctor choose the best treatment plan. Many Univfy Providers have set up special financial programs to help women afford more than one cycle of treatment, including refund programs and special multi-cycle discount programs.

Univfy^®-Powered IVF Refund Program

IVF is one of the most effective fertility treatments available today. That’s why many patients are considering it. Now, one can feel confident about choosing the best treatment plan and the ability to afford it.

The Univfy Platform helps IVF centres develop special pricing programs that make multiple IVF treatments more affordable. Every woman has a much higher chance of conceiving with IVF if she could afford to have at least 2 or 3 treatments.

Unlike traditional refund programs (or shared risk programs) that qualify very few patients, The Univfy Platform — using machine learning and AI — can qualify 50-80% of patients for a refund program offer.

The CEO and Advisor

Mylene Yao, M.D.
Co-Founder and CEO

Dr Yao has led Univfy^® from founding through stages of technology invention and commercialization. She is now leading the team to scale Univfy's business. Her vision is to combine healthcare AI, fintech, and scientific validation to power women's access to fertility treatments that are safe and highly effective.

Dr Yao has over 20 years of experience in clinical and scientific research in reproductive medicine. Prior to founding Univfy, she was on the faculty at Stanford University, where she led NIH-funded fertility and embryo genetics research and developed the Univfy^® technology with the academic founding team.

Dr Yao graduated from medical school at the University of Toronto and completed her obstetrics and gynaecology residency training at McGill University. She received her clinical subspecialty training in reproductive endocrinology and infertility at Brigham and Women’s Hospital at Harvard University. Dr Yao received multiple research awards for her fertility research work, including pre-implantation embryo development, the role of stem cell genes in the embryo, and uterine receptivity at implantation. She is a co-author of the chapter on Infertility in Berek and Novak's Gynecology, the top medical textbook for obstetricians and gynaecologists.

Dr Yao has been honoured with The Bump - Moms: Movers and Makers (2016) and MM&M's Top 40 Healthcare Transformers (2017).

Wing H. Wong, PhD.
Co-Founder and Advisor

Professor Wong is the Stephen R. Pierce Family Goldman Sachs Professor in Science and Human Health and Professor in the Departments of Statistics (former chairman) and Biomedical Data Science at Stanford University.

“Knowing the success probabilities can help the patient and doctor better plan for a course of treatment, rather than thinking in terms of a single cycle at a time, to maximize the chances of having a baby and we provide the right solution for all this”